Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for flibanserin
Flibanserin (brand name Addyi) is used to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women [1].
It is specifically indicated for premenopausal women diagnosed with acquired, generalized HSDD [1].
Flibanserin is not indicated for other populations (such as postmenopausal women) or for sexual desire problems that do not meet the prescription criteria for acquired, generalized HSDD [1].
The medication is intended to help improve sexual desire in women with HSDD as defined in the indication [1].
[1] https://www.drugpatentwatch.com/patent/31745531-flibanserin
Other Questions About Flibanserin :